Myocardial damage in new coronavirus infection (review)

Introduction. Myocardial damage characteristic of novel coronavirus infection is a confirmed risk factor for its severe course and high mortality. There are biomarkers of this condition correlating with an unfavorable prognosis for the patient. However, the information on the problem of myocardial damage in the available literature is not fully systematic. It concerns pathogenesis, differential diagnosis of its causes, routing of patients with acute coronary syndrome. All the above is very important for choosing the right tactics of examination and treatment of patients, who are often limited in time. 
Aim. To summarize the data available at the time of writing from domestic and foreign researchers on the problem of myocardial damage and its main causes (acute coronary syndrome, myocarditis, stress cardiomyopathy) in COVID-19. 
Materials and methods. This review summarizes the data from articles published over the past two years found in PubMed, Google Scholar and eLIBRARY. 
Results. The authors tried to form a generalized modern understanding of the causes and structure of cardiovascular pathology and risk factors of its destabilization in patients infected with SARS-CoV-2, the markers of increased risk of COVID-infected heart and vascular diseases, the tactics of examination and treatment of this category of patients, routing individuals with acute coronary syndrome and its differential diagnosis with non-coronary heart diseases. The questions of organization and availability of the medical care in the conditions of the pandemic and social aspects of the world cardiology problems in the current situation have been studied. 
Conclusion. Patients with cardiovascular disease have a more severe prognosis of the severity and outcome of COVID-19, which is explained by its pathogenesis. The group at highest risk of lethal events is composed of individuals with signs of myocardial damage, the causes of which are the above mentioned conditions. Their differential diagnosis is a difficult clinical task, which requires a systematic analysis of the dynamics of clinical syndromes and data of additional diagnostic methods from routine to the most modern (high-tech) and, of course, deep knowledge of the present problem. The correct determination of the cause of myocardial damage and the choice of the right patient’s route through the treatment network determines the effectiveness of treatment and, therefore, the prognosis of the patient’s life. 

1. Holyshko V.S., Snezhitskiy V.A., Matsiyeuskaya N.V. Cardiovascular diseas in COVID-19 patients. Part 2. Journal of the Grodno State Medical University 2021; 19(1):5–9 (in Russian). https://doi.org/10.25298/2221-8785-2021-19-1-5-9

2. Hendren N.S., Grodin J.L., Drazner M.H. Unique Patterns of Cardiovascular Involvement in Coronavirus Disease2019. J. Card. Fail. 2020; 26(6):466–469. https://doi.org/10.1016/j.cardfail.2020.05.006

3. Nagamani R., Rao N.S., Marulashresta G.D. A study of cardiovascular involvement in Covid-19 patients. International Journal of Medical and Health Research 2020; 6(12):P.112–117. https://www.medicalsciencejournal.com/archives/2020/vol6/issue12

4. Zheng Y.-Y., Ma Y.-T., Zhang J.-Y., Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020; 17(5):259–260. https://doi.org/10.1038/s41569-020-0360-5

5. Guan W.J., Liang W-H., Zhao Y., Liang H-R., Chen Z-Sh., Li Y-M., Liu X-Q., Chen R. Ch., Tang Ch-L., Wang T., Ou Ch-Q., Li L., Chen P-Y., Sang L., Wang W., Li J-F., Li C-Ch., Ou L-M., Cheng B., Xiong Sh., Ni Z-Y., Xiang J., Hu Y., Liu L., Shan H., Lei Ch-L., Peng Y-X., Wei K., Liu Y., Hu Y-H., Peng P., Wang J-M., Liu J-Y., Chen Z., Li G., Zheng Z-J., Qiu Sh-Q., Luo J., Ye Ch-J., Zhu Sh-Y., Cheng L-L., Ye F., Li Sh-Y., Zheng J-P., Zhang N-F., Zhong N-Sh., He J-X. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur. Respir. J. 2020; 55(5):2000547. https://doi.org/10.1183/13993003.00547-2020

6. Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn Th., Davidson K.W., Barnaby D.P., Becker L.B., Chelico J.D., Cohen S.L., Cookingham J., Coppa K., Diefenbach M.A., Dominello A.J., Duer-Hefele J., Falzon L., Gitlin J., Hajizadeh N., Harvin T.G., Hirschwerk D.A., Kim E.J., Kozel Z.M., Marrast L.M., Mogavero J.N., Osorio G.A., Qiu M., Zanos T.P. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020; 323(20):2052–2059. https://doi.org/10.1001/jama.2020.6775

7. Onder G., Rezza G., Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID19 in Italy. JAMA 2020; 23(18):1775–1776. https://doi.org/10.1001/jama.2020.4683

8. Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5):846–848. https://doi.org/10.1007/s00134-020-05991-x

9. Odilov A.A., Tsimbalist N.S., Volkov A.V., Babichenko I.I. Histopathological characteristics of multi-organ lesions in patients with COVID-19. Meditsinskaya nauka i obrazovanie Urala 2021; (1):53–60 (in Russian). https://doi.org/10.36361/1814-8999-2021-22-1-53-60

10. Antoshkin O.N., Vorotnikova T.V. Analysis of complications from coronavirus infection Codiv-19 according to pathologoanatomic studies. Journal of Volgograd State Medical University 2021; (2):156–159 (in Russian). https://doi.org/10.19163/1994-9480-2021-2(78)-156-159

11. Lindner D., Fitzek A., Bräuninger H., Aleshcheva G., Edler C., Meissner K., Scherschel K., Kirchhof P., Escher F., Schultheiss H-P., Blankenberg S., Püschel K., Westermann D. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020; 5(11):1281–1285. https://doi.org/10.1001/jamacardio.2020.3551

12. Rybakova M.G., Karev V.E., Kuznetsova I.A. Anatomical pathology of novel coronavirus (COVID-19) infection. First impressions. Arkh. Patol. 2020; 82(5):5–5 (in Russian). https://doi.org/10.17116/patol2020820515

13. Vertkin A.L., Zayratyants O.V., Kebina A.L., Sycheva A.S., Kuandykova M.V., Nosova A.V., Krasnenkova S.F., Astakhova O.I., Zavyalov G.V. COVID-19 clinical masking: clinical and morphological comparisons. Therapy 2020; (7):102–112 (in Russian). https://doi.org/10.18565/therapy.2020.7.102-112

14. De Silva Costa I.B.S., Bittar C.S., Rizk S.I., de Araújo Filho A.E., Santos K.A.Q., Machado T.I.V., de Almeida Andrade F.T., González T.B., Arévalo A.N.G., de Almeida J.P., Bacal F., de Oliveira G.M.M., de Lacerda M.V.G., Barberato S.H., Chagas A.C.P., Rochitte C.E., Ramires J.A.F., Filho R.K., Hajjar L.A. The Heart and COVID-19: What Cardiologists Need to Know. Arq. Bras. Cardiol. 2020; 114(5): 805–816. https://doi.org/10.36660/abc.20200279

15. Mamedov M.N., Rodionova Yu.V., Yavelov I.S., Smirnova M.I., Dudinskaya E.N., Potievskaya V.I. COVID-19 from the interdisciplinary standpoint. Round table. Cardiovascular Therapy and Prevention 2021; 20(3):73–86 (in Russian). https://doi.org/10.15829/1728-8800-2021-2849

16. Shakhmatova O.O., Panchenko E.P., Balakhonova T.V., Makeev M.I., Mironov V.M., Blankova Z.N., Butorova E.A. Cardiomyopathy and multiple arterial thrombosis in a patient with severe tachyform atrial fibrillation after COVID19. Aterotromboz = Atherothrombosis 2021; (1):6–24 (in Russian). https://doi.org/10.21518/2307-1109-2021-11-1-6-24

17. Ansheles A.A., Sergienko V.B., Sinitsyn V.E., Vakhromeeva M.N., Kokov A.N., Zavadovsky K.V., Ryzhkova D.V., Karalkin A.V., Shurupova I.V., Pospelov V.A., Migunova E.V., Saifullina G.B, Hirschfeld C., Williams M.C., Shaw L.J., Malkovskiy E., Better N., Cerci R., Dorbala Sh., Pascual T.N.B., Raggi P., Villines T., Vitola J.V., Pynda Y., Dondi M., Paez D., Einstein A.J. Impact of the first wave of coronavirus disease 2019 (COVID-19) pandemic on the diagnosis of heart disease in the Russian Federation: results from the Russian segment of the IAEA INCAPS COVID study. Russian Journal of Cardiology 2021; 26(1):105–118 (in Russian). https://doi.org/10.15829/1560-4071-2021-4276

18. Keizman E., Ram E., Kachel E., Sternik L., Raanani E. The impact of COVID-19 pandemic on cardiac surgery in Israel. J. Cardiothorac. Surg. 2020; 15(1):294. https://doi.org/10.1186/s13019-020-01342-5

19. Banerjee A., Chen S., Pasea L., Lai A.G., Katsoulis M., Denaxas S., Nafilyan V., Williams B., Wong W.K., Bakhai A., Khunti K., Pillay D., Noursadeghi M., Wu H., Pareek N., Bromage D., McDonagh T.A., Byrne J., Teo J.T.H., Shah A.M., Humberstone B., Tang L.V., Shah A.S.V., Rubboli A., Guo Y., Hu Y., Sudlow C.L.M., Lip G.Y.H., Hemingway H. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur. J. Prev. Cardiol. 2021; zwaa155. https://doi.org/10.1093/eurjpc/zwaa155

20. De Rosa S., Spaccarotella C., Basso C., Calabrò M.P., Curcio A., Filardi P.P., Mancone M., Mercuro G., Muscoli S., Nodari S., Pedrinelli R., Sinagra G., Indolfi C. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur. Heart J. 2020; 41(22):2083–2088. https://doi.org/10.1093/eurheartj/ehaa409

21. Martsevich S.Y., Lukina Y.V., Zharkova E.D., Kutishenko N.P. Treatment Adherence to Drug Therapyin Patients with Stable Coronary Artery Disease During the COVID-19 Pandemic. Rational Pharmacotherapy in Cardiology 2021; 17(1):99–104 (in Russian). https://doi.org/10.20996/1819-6446-2021-01-06

22. Kostev K., Kumar S., Konrad M., Bohlken J. Prescription rates of cardiovascular and diabetes therapies prior to and during the COVID-19 lockdown in Germany. Int. J. Clin. Pharmacol. Ther. 2020; 58(9):475–481. https://doi.org/10.5414/CP203849

23. Sergienko I.V., Rezinkina P.K. New coronavirus infection COVID-19 and cardiovascular disease. Therapy features. The Journal of Atherosclerosis and Dyslipidemias 2021; (2):5–23 (in Russian). https://doi.org/10.34687/2219-8202.JAD.2021.02.0001

24. Voronina T.A. Antioxidants/antihypoxants: the missing puzzle piece in effective pathogenetic therapy for COVID19. Infekc. bolezni (Infectious diseases) 2020; 18(2):97–102 (in Russian). https://doi.org/10.20953/1729-9225-2020-2-97-102

25. Kozlov I.A., Tyurin I.N. Cardiovascular complications of COVID-19. Messenger of Anesthesiology and Resuscitation 2020; 17(4):14–22 (in Russian). https://doi.org/10.21292/2078-5658-2020-17-4-14-22

26. Shi Sh., Qin M., Shen B., Cai Y., Liu T., Yang F., Gong W., Liu X., Liang J., Zhao Q., Huang H., Yang B., Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5(7):802–810. https://doi.org/10.1001/jamacardio.2020.0950

27. Guo T., Fan Y., Chen M., Wu X., Zhang L., He T., Wang H., Wan J., Wang X., Lu Zh. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):811–818. https://doi.org/10.1001/jamacardio.2020.1017

28. Siripanthong B., Nazarian S., Muser D., Deo R., Santangeli P., Khanji M.Y., Cooper L.T.Jr, Chahal C.A.A. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 2020; 17(9):1463–1471. https://doi.org/10.1016/j.hrthm.2020.05.001

29. Blagova O.V., Varionchik N.V., Zaydenov V.A., Savina P.O., Sarkisova N.D. Anticardiac antibodies in patients with severe and moderate COVID-19 (correlations with the clinical performance and prognosis). Russian Journal of Cardiology 2020;25(11):4054 (in Russian). https://doi.org/10.15829/29/1560-4071-2020-4054

30. Kim I-Ch., Kim J.Y., Kim H.A., Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur. Heart J. 2020; 41(19):1859. https://doi.org/10.1093/eurheartj/ehaa288

31. Kogan E.A., Berezovsky Y.S., Protsenko D.D., Bagdasaryan T.R., Gretzov E.M., Demura S.A., Demyashkin G.A., Kalinin D.V., Kukleva A.D., Kurilina E.V., Nekrasova T.P, Paramonova N.B., Ponomarev A.B., Radenska-Lopovok S.G., Semenova L.A., Tertychny A.S. Pathological anatomy of infection caused by SARS-CoV-2. Russian Journal of Forensic Medicine 2020; 6(2):8–30 (in Russian). https://doi.org/10.19048/2411-8729-2020-6-2-8-30

32. Escher F., Pietsch H., Aleshcheva G., Bock Th., Baumeier Ch., Elsaesser A., Wenzel Ph., Hamm Ch., Westenfeld R., Schultheiss M., Gross U., Morawietz L., Schultheiss H-P. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Fail. 2020; 7(5):2440–2447. https://doi.org/10.1002/ehf2.12805

33. Lindner D., Fitzek A., Bräuninger H., Aleshcheva G., Edler C., Meissner K., Scherschel K., Kirchhof P., Escher F., Schultheiss H-P., Blankenberg S., Püschel K., Westermann D. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020; 5(11):1281–1285. https://doi.org/10.1001/jamacardio.2020.3551

34. Sharma A., Garcia G. Jr, Wang Y., Plummer J.T., Morizono K., Arumugaswami V., Svendsen C.N. Human iPSCDerived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection. Cell Rep. Med. 2020; 1(4):100052. doi: 10.1016/j.xcrm.2020.100052

35. Kogan E.A., Berezovsky Yu.S., Kukleva A.D., Kurilina E.V., Semenova L.A., Blagova O.V., Zharkov N.V. Lymphocytic myocarditis in patients with COVID-19 (4 autopsy cases). Arkh. Patol. 2020; 82(5):57–62 (in Russian). https://doi.org/10.17116/patol20208205157

36. Ebzeeva E.Yu., Mironova E.V., Krotkova I.F., Ostroumova O.D., De V.A. The new coronavirus infection followed by damage to the heart, lungs, skin and kidneys. Kardiologiya i Serdechno-Sosudistaya Khirurgiya 2021;14(1):104–110 (in Russian). https://doi.org/10.17116/kardio202114011104

37. Argulian E., Sud K., Vogel B., Bohra Ch., Garg V.P., Talebi S., Lerakis S., Narula J. Right Ventricular Dilation in Hospitalized Patients with COVID-19 Infection. JACC Cardiovasc. Imaging 2020; 13(11):2459–2461. https://doi.org/10.1016/j.jcmg.2020.05.010

38. Gumerov R.M., Gareeva D.F., Davtyan P.A., Rakhimova R.F., Musin T.I., Zagidullin S.Z., Pushkareva A.E., Plotnikova M.R., Ishmetov V.S., Pavlov V.N., Motloch L.J., Zagidullin N.S. Serum biomarkers of cardiovascular complications in COVID-19. Russian Journal of Cardiology 2021; 26(2S):4456 (in Russian). https://doi.org/10.15829/1560-4071-2021-4456

39. Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M., Metra M., Curello S., Maffeo D., Pero G., Cacucci M., Assanelli E., Bellini B., Russo F., Ielasi A., Tespili M., Danzi G.B., Vandoni P., Bollati M., Barbieri L., Oreglia J., Lettieri C., Cremonesi A., Carugo S., Reimers B., Condorelli G., Chieffo A. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic. Circulation 2020; 141 (25):2113–2116. https://doi.org/10.1161/CIRCULATIONAHA.120.047525

40. Bangalore S., Sharma A., Slotwiner A., Yatskar L., Harari R., Shah B., Harari R., Shah B., Ibrahim H., Friedman G.H., Thompson C., Alviar C.L., Chadow H.L., Fishman G.I., Reynolds R., Keller N., Hochman J.S. ST-Segment Elevation in Patients with Covid-19 – A Case Series. N. Engl. J. Med. 2020; 382(25):2478–2480. https://doi.org/10.1056/NEJMc2009020

41. Lippi G., Plebani M. Laboratory abnormalities in patients with COVID ‑ 2019 infection. Clin. Chem. Lab. Med. 2020; 58(7):1131–1134. https://doi.org/10.1515/cclm-2020-0198

42. Shlyakhto E.V., Parmon E.V., Berngardt E.R., Zhabina E.S. Features of electrocardiographic changes in non-coronarogenic syndromes in patients with COVID-19. Russian Journal of Cardiology 2020; 25(7):194–200 (in Russian). https://doi.org/10.15829/1560-4071-2020-4019

43. Karpunina N.S., Khlynova O.V., Shumovich I.V. Heart injury in COVID-19: immediate and long-term follow-up. Perm Medical Journal 2021; 38(3):48–60 (in Russian). https://doi.org/10.17816/pmj38348-60

44. Petrikov S.S., Ivannikov A.A., Vasilchenko M.K., Esaulenko A.N., Alidzhanova K.G. COVID-19 and Cardiovascular System: Pathophysiology, Pathomorphology, Complications, Long-Term Prognosis. Russian Sklifosovsky Journal "Emergency Medical Care" 2021; 10(1):14–26. https://doi.org/10.23934/2223-9022-2021-10-1-14-26

45. Savchenko S.V., Lamanov A.N., Novoselov V.P., Gritsinger V.A., Miguel M.A., Novikov A.I.. Morphological changes in the heart and blood vessels under new coronavirus infection (COVID-19). Journal of forensic medicine 2021; 10(2):40–44 (in Russian).

46. Moderato L., Monello A., Lazzeroni D., Binno S., Giacalone R., Ferraro S., Piepoli M.F., Villani G.Q. Takotsubo syndrome during SARS-CoV-2 pneumonia: a possible cardiovascular complication. G. Ital. Cardiol. (Rome) 2020; 21(6):417–420 (in Italy). https://doi.org/10.1714/3359.33323

47. Kazantseva L.S., Bryleva L.I., Tatarnikov A.N., Kazantsev V.N., Veselova E.V., Shapovalov K.G. Multisystemic inflammatory syndrome associated with novel coronavirus infection (COVID-19) in children. The Transbaikalian Medical Bulletin 2021; (2):127–136 (in Russian). https://doi.org/10.52485/19986173_2021_2_127

48. Ramcharan T., Nolan O., Lai Ch.Y., Prabhu N., Krishnamurthy R., Richter A.G., Jyothish D., Kanthimathinathan H.K., Welch S.B., Hackett S., Al-Abadi E., Scholefield B.R., Chikermane A. Paediatric Inflammatory Multisystem Syndrome: Temporarily Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatr. Cardiol. 2020; 41(7):1391–1401. https://doi.org/10.1007/s00246-020-02391-2

49. Gribanov V.P., Kirillov A.S., Vavilov I.A., Ozerova E.D., Lomaichikov V.V. Acute pericarditis in patient with COVID-19: pre-hospital and in-hospital follow-up stages. Medical alphabet 2021; 1(11):60–64 (in Russian). https://doi.org/10.33667/2078-5631-2021-11-60-64

50. O'Gallagher K., Kanyal R., Sado D., Byrne J. COVID-19 Myopericarditis. American College of Cardiology (ACC); 2020. https://www.acc.org/latest-in-cardiology/articles/2020/09/25/17/22/covid-19-myopericarditis

51. Hamadeh A., Aldujeli A., Briedis K., Klinikos K., Tecson K.M., Sanchez K.J., Al-Dujeili M.., Al-Obeidi A., Díez J.L., Žaliūnas R., Stoler R., McCullough P.A. Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction. Am. J. Cardiol. 2020; 131:1–6. https://doi.org/10.1016/j.amjcard.2020.06.063

52. Shlyakhto E.V., Conradi A.O., Arutyunov G.P., Arutyunov A.G., Bautin A.E., Boitsov S.A., Villevalde S.V., Grigorieva N.Y., Dulyakov D.V., Zvartau N.E, Koziolova N.A., Lebedev D.S., Malchikova S.V., Medvedeva E.A., Mikhailov E.N., Moiseeva O.M., Orlova Y.A., Pavlova T.V., Pevzner D.V., Petrova M.M., Rebrov A.P, Sitnikova M.Y., Solovieva A.E., Tarlovskaya E.I., Trukshina M.A., Fedotov P.A., Fomin I.V., Khripun A.V., Chesnikova A.I., Shaposhnik I.I., Yavelov I.S., Yakovlev A.N. Guidelines for diagnosis and treatment of circulatory diseases in the context of COVID-19 pandemic. Russian Journal of Cardiology 2020; 25(3):3801 (in Russian). https://doi.org/10.15829/1560-4071-2020-3-3801

53. Zhang L., Fan Y., Lu Z. Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by 'on the scene' cardiologists. Eur. Heart J. 2020; 41(19):1788–1790. https://doi.org/10.1093/eurheartj/ehaa266

54. Jing Z-C., Zhu H-D., Yan X-W., Chai W-Z., Zhang S. Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak. Eur. Heart J. 2020; 41(19):1791–1794. https://doi.org/10.12691/ajmcr-8-11-3

55. Zeng J., Huang J., Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital. Intensive Care Med. 2020; 46 (6):1111–1113. https://doi.org/10.1007/s00134-020-05993-9

56. Courand P-Y., Harbaoui B., Bonnet M., Lantelme P. Spontaneous Coronary Artery Dissection in a Patient With COVID-19. JACC Cardiovasc. Interv. 2020; 13(12):107–108. https://doi.org/10.1016/j.jcin.2020.04.006

57. Mahmud E., Dauerman H.L., Welt F.G. Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). J. Am. Coll. Cardiol. 2020; 76(11):1375–1384. https://doi.org/10.1016/j.jacc.2020.04.039

58. Chieffo A., Stefanini G.G., Price S. EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. Eur. Heart J. 2020; 41(19):1839–1851. https://doi.org/10.1093/eurheartj/ehaa381

59. Prevention, diagnosis and treatment of emerging coronavirus infection (COVID-19). Version 11. Provisional guidelines (approved by the Ministry of Health of the Russian Federation on 7 May 2021). Available at: http://nasci.ru/?id=40123

60. Namitokov A.M., Ishevskaya O.P., Fetisova V.I., Kosmacheva E.D., Porkhanov V.A. Diagnosis and treatment of acute coronary syndrome during the novel coronavirus infection COVID-19 pandemic. Russian Journal of Cardiology 2020; 25(4):3854 (in Russian). https://doi.org/10.15829/1560-4071-2020-3854